Pregnant woman

Halting certain medication for pregnant women could save NHS £20m a year, study shows

The NHS could be set to save £20m per year after a new study showed that a medication for inherited blood clotting doesn’t increase the chance of a successful pregnancy.

The ALIFE2 trial found the drug known as heparin, which is typically prescribed to pregnant women with acquired blood clotting disorders, is not effective for pregnant women with an inherited blood clotting condition called thrombophilia.

To conduct their research, health professionals recruited 326 women from 40 hospitals around the world who had inherited thrombophilia and two or more miscarriages.

Around half of the women received daily injections of heparin starting from their positive pregnancy test right up until labour. The other half were not offered the medication.

The study, which was funded by the National Institute for Health and Care Research, showed that the rate of live births was similar while the risk of complications like placental abruption, pre-eclampsia and premature birth were also about the same across both groups.

Deputy director at Tommy’s National Centre for Miscarriage Research, Professor Siobhan Quenby, led the research.

"Many women with recurrent miscarriage around the world are tested for inherited thrombophilia and are treated with heparin daily,” said Prof Quenby.

“Research now shows that this screening is not needed, the treatment isn’t effective, and it is giving false hope to many by continuing to offer it as a potential preventive treatment."

The researchers say that if the NHS ended the screening and stopped treating inherited thrombophilia with heparin, it could save approximately £20m annually.

Read the full study findings here.

NHE September/October 2023

NHE September/October 2023

Empowering the next generation to lead the way in hard-to-treat cancers.

The September/October 2023 edition of NHE brings you expert comment and analysis on a range of key health sector topics, from digital transformation to navigating post-pandemic challenges.


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Events

NHE has created a full calendar of events to address the most important issues that influence the delivery of healthcare services. Over 365 days you'll have the opportunity to hear from a range of highly motivating, informative and inspirational speakers. These speakers will equip you with the knowledge and unique insight to enable you to overcome the challenges that you face.

National Health Executive Podcast

Ep. 36
How interoperability can support the NHS's core goals
with Ed Platt

In episode 36 of the National Health Executive podcast, we were joined by Omnicell’s UK professional services director, Ed Platt, to discuss interoperability in the NHS, practical examples of where it can be leveraged best, the importance of the health service's digital transformation journey and more.

More articles...

View all